Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

A unified statistical approach for determining significant signals in images of cerebral activation.

Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC.

Hum Brain Mapp. 1996;4(1):58-73. doi: 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O.

PMID:
20408186
2.

Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory.

Tan HY, Chen Q, Goldberg TE, Mattay VS, Meyer-Lindenberg A, Weinberger DR, Callicott JH.

J Neurosci. 2007 Dec 5;27(49):13393-401.

3.

Fine mapping versus replication in whole-genome association studies.

Clarke GM, Carter KW, Palmer LJ, Morris AP, Cardon LR.

Am J Hum Genet. 2007 Nov;81(5):995-1005. Epub 2007 Sep 19.

4.

Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum.

Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Männistö PT.

J Neurosci. 2007 Sep 19;27(38):10196-209.

5.

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, O'Neill FA, Walsh D, Van den Oord EJ, Kendler KS, Riley BP.

Biol Psychiatry. 2008 Mar 1;63(5):449-57. Epub 2007 Sep 6.

6.

Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function.

Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF, Mattay VS, Meyer-Lindenberg A, Weinberger DR, Callicott JH.

Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12536-41. Epub 2007 Jul 16.

7.

Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls.

Genderson MR, Dickinson D, Diaz-Asper CM, Egan MF, Weinberger DR, Goldberg TE.

Schizophr Res. 2007 Aug;94(1-3):231-9. Epub 2007 Jun 13.

PMID:
17570645
8.
9.

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA.

J Neurosci. 2007 May 2;27(18):4832-8.

10.

Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms.

Sei Y, Ren-Patterson R, Li Z, Tunbridge EM, Egan MF, Kolachana BS, Weinberger DR.

Mol Psychiatry. 2007 Oct;12(10):946-57. Epub 2007 Apr 17.

PMID:
17440436
12.

Association analysis of AKT1 and schizophrenia in a UK case control sample.

Norton N, Williams HJ, Dwyer S, Carroll L, Peirce T, Moskvina V, Segurado R, Nikolov I, Williams NM, Ikeda M, Iwata N, Owen MJ, O'Donovan MC.

Schizophr Res. 2007 Jul;93(1-3):58-65. Epub 2007 Mar 26.

PMID:
17383860
13.

The Akt-GSK-3 signaling cascade in the actions of dopamine.

Beaulieu JM, Gainetdinov RR, Caron MG.

Trends Pharmacol Sci. 2007 Apr;28(4):166-72. Epub 2007 Mar 8. Review.

PMID:
17349698
14.

Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.

Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR.

J Clin Invest. 2007 Mar;117(3):672-82. Epub 2007 Feb 8.

15.

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF.

Nat Neurosci. 2007 Mar;10(3):376-84. Epub 2007 Feb 4.

PMID:
17277774
16.

No gene is an island: the flip-flop phenomenon.

Lin PI, Vance JM, Pericak-Vance MA, Martin ER.

Am J Hum Genet. 2007 Mar;80(3):531-8. Epub 2007 Jan 22. Erratum in: Am J Hum Genet. 2007 May;80(5):1002.

17.

Cancer risk among parents and siblings of patients with schizophrenia.

Levav I, Lipshitz I, Novikov I, Pugachova I, Kohn R, Barchana M, Ponizovsky A, Werner H.

Br J Psychiatry. 2007 Feb;190:156-61.

PMID:
17267933
18.

Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.

Wei Y, Williams JM, Dipace C, Sung U, Javitch JA, Galli A, Saunders C.

Mol Pharmacol. 2007 Mar;71(3):835-42. Epub 2006 Dec 12.

19.

IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates.

Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, Winstanley CA, Renthal NE, Wiley MD, Self DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ.

Nat Neurosci. 2007 Jan;10(1):93-9. Epub 2006 Dec 3.

PMID:
17143271
20.

Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning.

Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, Karayiorgou M, Gogos JA.

Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16906-11. Epub 2006 Oct 31.

Supplemental Content

Support Center